Clinical trial
Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are…
NCT00107510 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00107510 |
|---|---|
| Title | Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer |
| Official title | Phase II Trial of Docetaxel and Carboplatin Administered Every Two Weeks as Induction Therapy for Stage II or III Breast Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Biological, Drug, Procedure |
| Interventions | pegfilgrastim, carboplatin, docetaxel, conventional surgery |
| Enrollment | 58 |
| Start date | Aug 1, 2005 |
| Primary completion | Sep 1, 2007 |
| First posted | Apr 6, 2005 |
| Last update posted | Jul 6, 2016 |
| Countries | United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: